Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes
Introduction
Central nervous system (CNS) aberrations resulting from prolonged exposure to transition metals, such as iron (Febbraro et al., 2012, Galvin et al., 2000, Gregory et al., 2009), lead (Bihaqi and Zawia, 2013), and manganese (Gorojod et al., 2015, Hesketh et al., 2008), lend support to the potential involvement of environmental metal exposure in the etiology of chronic neurodegeneration (Rokad et al., 2016). Manganese (Mn) toxicity resulting from overexposure to airborne sources was first noted in miners (Peres et al., 2016, Rodier, 1955), and subsequently in industrial workers like welders (Horning et al., 2015, Kwakye et al., 2015). Although Mn has a multitude of physiological functions (e.g., enzyme cofactor for superoxide dismutase and arginase, immunity, bone development, and reproduction) (Karki et al., 2015), the accruing toxic levels has been shown to predominately localize to the globus pallidus, as well as other brain areas of the extrapyramidal motor system, thereby leading to a condition termed manganism, which is phenotypically similar to PD (Kwakye et al., 2015, Milatovic et al., 2007). In addition, diets including grains, legumes, baby formulations and nuts represent the main source of Mn, of which <5% is intestinally absorbed (Karki et al., 2013, Kwakye et al., 2015). Approximately, 30–40% of inhaled Mn is absorbed into the bloodstream, where it is transported primarily bound to albumin and β-globulin in oxidation state 2 (Mn2+) (Karki et al., 2013); however, the absorbed proportion could be smaller (∼10.6%) because of oxidative state-dependent differences in solubility (Ellingsen et al., 2003). Availability of the Mn2+ oxidation state in the central nervous system (CNS) is facilitated by transporters such as divalent metal ion transporter 1 (DMT1) and SLC13A10, while Mn3+ is facilitated by transferrin (Chen et al., 2015, Karki et al., 2015, Leyva-Illades et al., 2014, Sidoryk-Wegrzynowicz and Aschner, 2013).
As a ubiquitous constituent and physiological glue of the CNS, astrocytes are indispensable for cellular homeostatic maintenance (Volterra and Meldolesi, 2005). Astrocytes regulate extracellular glutamate levels among neurons in tripartite synapses (Karki et al., 2013, Popoli et al., 2011). Excessive Mn can disrupt this regulation by inducing tumor necrosis factor-α (TNFα), a secreted proinflammatory cytokine. Previous studies demonstrated that Mn impairs calcium (Ca2+) homeostasis in astrocytes and activates key proinflammatory events such as NFκB, NOS2 and cytokine production (Karki et al., 2014, Karki et al., 2015). This inflammatory response increases expression of yin yang-1, a transcription repressor that inhibits production of excitatory amino acid transporter-2, which is necessary for glutamate reuptake (Karki et al., 2014, Karki et al., 2015). Recent studies also demonstrate that Mn interferes with neurodegenerative disease-specific proteins including prions, alpha-synuclein, and huntingtin (Bichell et al., 2017, Choi et al., 2007, Choi et al., 2010, Harischandra et al., 2015), as well as protein misfolding, which may further contribute to neuroinflammation. Thus, Mn exposure can activate the inflammatory response in astrocytes, which can further contribute to Mn neurotoxicity.
Along with pericytes, the end-feet of astrocytes envelope blood vessels to regulate blood–brain barrier trafficking (Pekny and Pekna, 2014). Interestingly, astrocytes have been demonstrated to have an increased affinity for Mn, with concentrations up to 50-fold greater than in neurons (Aschner et al., 1992, Gonzalez et al., 2008). Once internalized, Mn is sequestered by mitochondria via the Ca2+ uniporter (Gunter et al., 2006). Kinetical analyses revealed the influx of Mn through this mitochondrial uniporter is slower than Ca2+ per se, but Mn efflux is far slower (Gavin et al., 1990, Martinez-Finley et al., 2013). Even though the atomic charge properties and size of Mn are quite analogous to Ca2+, the two Ca2+ efflux mechanisms are poor exporters of Mn, thus explaining the mitochondrial sequestration of Mn (Gunter et al., 1975, Gunter and Sheu, 2009, Martinez-Finley et al., 2013). On the other hand, although sodium (Na+)-independent Ca2+ efflux does transport Mn, Na+-dependent Ca2+ efflux, the predominant mechanism in CNS mitochondria, has not been reported to export Mn (Gavin et al., 1990, Gunter and Sheu, 2009, Martinez-Finley et al., 2013). This extremely sluggish efflux of Mn potentially explains the prolonged CNS clearance and the buildup of toxicity (Martinez-Finley et al., 2013). Mn can also competitively inhibit both efflux pathways, thereby raising the mitochondrial Ca2+ concentration, which can impair aerobic respiration and elicit reactive oxygen species (ROS) generation (Gavin et al., 1990, Martinez-Finley et al., 2013, Streifel et al., 2013, Tjalkens et al., 2006).
Despite the known effects of Mn on astrocytes, the extent of Mn-induced structural and functional impairment of mitochondrial dynamics and its consequent neuroinflammatory processes as it relates to Mn neurotoxicity have not been systematically examined. In the present study, we characterized the impact of Mn on mitochondrial bioenergetic flux in astrocytes (using the Seahorse bioenergetic analyzer) and its functional consequence on neuroinflammation. Our results demonstrate that overexposure to Mn (i) lowers basal respiration in astrocytes, (ii) induces astrocytic inflammation that is not exclusive to TNFα, and (iii) potentiates aggregated α-synuclein (αSynagg)-induced inflammation in astrocytes. Thus, our study establishes a functional interaction between mitochondrial dysfunction and astrocytic inflammation in Mn-induced neurotoxicity. In addition, we report that the mitochondria-targeted anti-oxidant mito-apocynin attenuates Mn-induced astrocyte inflammation.
Section snippets
Chemicals and reagents
Dulbecco's modified eagle medium (DMEM), fetal bovine serum (FBS), l-glutamine (Q), and penicillin/streptomycin (P/S) were obtained from Invitrogen (Carlsbad, CA). MitoTracker Green FM and MitoTracker Red CMXRos, were purchased from Molecular Probes (Eugene, OR). Manganese chloride (MnCl2) was obtained from Sigma–Aldrich (St. Louis, MO). The CellTiter® 961 AQueous Non-Radioactive Cell Proliferation Assay kit and CellTiter® Glo Luminescent Cell Viability Assay kit were obtained from Promega
Mn induced a dose-dependent decrease in mitochondrial metabolic activity in astrocytes
Mn has been shown to accumulate in mitochondria, block the electron transport chain (ETC), and alter mitochondrial permeability in astrocytes (Hazell, 2002, Rao and Norenberg, 2004). In this experiment, we examined the effect of Mn on metabolic activity in PMA and U373 cells. Both sets of astrocytes were exposed to increasing concentrations of Mn (0.001–1 mM) for 24 h. We observed a dose-dependent decrease in metabolic activity as determined by MTS assay. The IC50 for inhibiting metabolic
Discussion
Neuroinflammation plays a key role in neurodegenerative disorders, including Parkinsonian syndrome (Glass et al., 2010, Golde, 2002, Herrero et al., 2015, Tansey and Goldberg, 2010, Whitton, 2007). Even though the etiology of these diseases is not well established, the consensus is that environment plays an important role in these neurodegenerative disorders. Astrocytes, the most abundant glial cells of the brain, are a recognized source of sustained inflammation upon activation (Phillips et
Conflict of interest
A.G.K. and V.A. are shareholders of PK Biosciences Corporation (Ames, IA), which is interested in identifying novel biomarkers and potential therapeutic targets for PD. A.G.K and V.A. do not have any direct financial interest in the work presented in present work.
Transparency document
Acknowledgements
This work was supported by National Institutes of Health (NIH) Grants: ES026892, ES10586, and NS088206. The authors would like to thank Dr. Balaraman Kalyanaraman for providing access to mito-apocynin. Lloyds chair to A.G.K. and Salsbury Chair to A.K. are also acknowledged.
References (90)
- et al.
Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line
Neurosci. Res.
(2011) - et al.
Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb)
Neurotoxicology
(2013) - et al.
Effect of intranasal manganese administration on neurotransmission and spatial learning in rats
Toxicol. Appl. Pharmacol.
(2012) - et al.
Alterations in mitochondrial dynamics induced by tebufenpyrad and pyridaben in a dopaminergic neuronal cell culture model
Neurotoxicology
(2016) - et al.
Oxidative stress involves in astrocytic alterations induced by manganese
Exp. Neurol.
(2002) - et al.
Astrocytes: key regulators of neuroinflammation
Trends Immunol.
(2016) - et al.
Old age and gender influence the pharmacokinetics of inhaled manganese sulfate and manganese phosphate in rats
Toxicol. Appl. Pharmacol.
(2004) - et al.
Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology
Am. J. Pathol.
(2000) - et al.
The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease
J. Biol. Chem.
(2013) - et al.
Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro
J. Biol. Chem.
(1999)
Mechanisms underlying inflammation in neurodegeneration
Cell
Manganese activates the mitochondrial apoptotic pathway in rat astrocytes by modulating the expression of proteins of the Bcl-2 family
Neurochem. Int.
A simple magnetic separation method for high-yield isolation of pure primary microglia
J. Neurosci. Methods
Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease
Neurobiol. Dis.
The autophagic-lysosomal pathway determines the fate of glial cells under manganese-induced oxidative stress conditions
Free Radic. Biol. Med.
Nasal drug administration: potential for targeted central nervous system delivery
J. Pharm. Sci.
Quantitative magnetic resonance studies of manganese uptake by mitochondria
Biophys. J.
Speciation of manganese in cells and mitochondria: a search for the proximal cause of manganese neurotoxicity
Neurotoxicology
Characteristics and possible functions of mitochondrial Ca(2+) transport mechanisms
Biochim. Biophys. Acta
Environmental neurotoxicant manganese regulates exosome-mediated extracellular miRNAs in cell culture model of Parkinson's disease: relevance to α-synuclein misfolding in metal neurotoxicity
Neurotoxicology
Astrocytes and manganese neurotoxicity
Neurochem. Int.
Elevated manganese levels in blood and CNS in human prion disease
Mol. Cell. Neurosci.
Effect of divalent metals on the neuronal proteasomal system, prion protein ubiquitination and aggregation
Toxicol. Lett.
Role of transcription factor yin yang 1 in manganese-induced reduction of astrocytic glutamate transporters: putative mechanism for manganese-induced neurotoxicity
Neurochem. Int.
IPAF inflammasome is involved in interleukin-1beta production from astrocytes, induced by palmitate; implications for Alzheimer's disease
Neurobiol. Aging
Overexpression of mitofusin 2 inhibits reactive astrogliosis proliferation in vitro
Neurosci. Lett.
Manganese neurotoxicity and the role of reactive oxygen species
Free Radic. Biol. Med.
Intranasal exposure to manganese disrupts neurotransmitter release from glutamatergic synapses in the central nervous system in vivo
Neurotoxicology
Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation
J. Biol. Chem.
Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity
Neurotoxicology
Induction of oxidative stress and inflammatory cytokines by manganese chloride in cultured T98G cells, human brain glioblastoma cell line
Toxicol. In Vitro
Manganese induces the mitochondrial permeability transition in cultured astrocytes
J. Biol. Chem.
Manganese inhibits ATP-induced calcium entry through the transient receptor potential channel TRPC3 in astrocytes
Neurotoxicology
Synuclein activates microglia in a model of Parkinson's disease
Neurobiol. Aging
VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function
Cell Rep.
Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention
Neurobiol. Dis.
Manganese suppresses ATP-dependent intercellular calcium waves in astrocyte networks through alteration of mitochondrial and endoplasmic reticulum calcium dynamics
Brain Res.
Mitochondrial-dependent manganese neurotoxicity in rat primary astrocyte cultures
Brain Res.
Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells
Front. Cell. Neurosci.
Inflammation in neurodegenerative diseases
Immunology
Manganese uptake and efflux in cultured rat astrocytes
J. Neurochem.
Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model
Biochim. Biophys. Acta
Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy
Nanomedicine
SLC30A10: a novel manganese transporter
Worm
Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease
Toxicol. Sci.
Cited by (95)
Early-life manganese exposure during multiple developmental periods and adolescent verbal learning and memory
2023, Neurotoxicology and TeratologyMitochondrial dysfunction: A fatal blow in depression
2023, Biomedicine and PharmacotherapyPerspectives for advancing neurotoxicity studies with Drosophila
2023, Advances in NeurotoxicologyThe cGAS-STING-autophagy pathway: Novel perspectives in neurotoxicity induced by manganese exposure
2022, Environmental PollutionImplications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases
2022, Neurobiology of DiseaseMicroglial ion channels: Key players in non-cell autonomous neurodegeneration
2022, Neurobiology of Disease
- 1
These authors made equal contributions.